MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?
Profile
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.96M
P/E Ratio
N/A
Total Cash
134.18K
Projected Growth
N/A
Total Debt
1.07M
Revenue
N/A
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
12.07 USD as % of share price
Fundamentals
INM
Capitalization
73M
P/E Ratio
N/A
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash
134K
Total Cash/Share
0.19
Total Debt
1.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.07%
Revenue
N/A
ROE
N/A
Book Value
11.1M
P/B Ratio
7.92
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
80.6M
Current Ratio
6.58
Current Revenue Per Employee
95400.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
24.69
Revenue To Assets
N/A
Shares Held By Institutions
333K
Shares Outstanding - Current
718K
Total Liabilities
2.25M
Total Volume MTD
N/A
Value
1
Gain YTD
-44.135
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com